- Concept UI
- M0001515
- Registry Numbers
- 0
- Scope Note
- Drugs used in the treatment of tuberculosis. They are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
- Terms
-
Antitubercular Agents
Preferred Term
Term UI
T003064
Date01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1966)
-
Antitubercular Agent
Term UI
T000999834
Date11/29/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anti-Tuberculosis Agent
Term UI
T000999835
Date11/29/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anti-Tuberculosis Drug
Term UI
T000999836
Date11/29/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Antitubercular Drug
Term UI
T000999838
Date11/29/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Tuberculostatic Agent
Term UI
T000999839
Date11/29/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anti-Tuberculosis Drugs
Term UI
T000999832
Date11/29/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anti-Tuberculosis Agents
Term UI
T000999833
Date11/29/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Antitubercular Drugs
Term UI
T003066
Date11/30/1994
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Tuberculostatic Agents
Term UI
T003065
Date12/30/1974
LexicalTag
NON
ThesaurusID
UNK (19XX)